New pyrrolidine?carboxamide derivatives as dual antiproliferative EGFR/CDK2 inhibitors
Chemical Biology and Drug Design
DECEMBER 27, 2023
Rational design of new targets. Abstract Cancer is one of the leading causes of mortality worldwide, making it a public health concern. A novel series of pyrrolidine-carboxamide derivatives 7a-q were developed and examined in a cell viability assay utilizing a human mammary gland epithelial cell line (MCF-10A), where all the compounds exhibited no cytotoxic effects and more than 85% cell viability at a concentration of 50 μM.
Let's personalize your content